'Antiviral treatment will have no change. Spike protein change may affect the immunity protection.'
The WHO's move came nearly three weeks after India objected to the B.1.617 mutant of the novel coronavirus being termed an 'Indian Variant' in media reports with the Union Health Ministry pointing out that the UN's top health organ has not used the word 'Indian' for this strain in its document.
The B-1617 variant of the coronavirus, first identified in India, has been classified as a variant of concern at the global level by the World Health Organisation (WHO).
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances